TABLE 5.
Multivariate Analysis of Predictors of Wait-List Dropout Because of Death or Delisting by Competing Risks
| Predictor | Multivariate HR (95% CI) |
P Value |
|---|---|---|
| Wait-time region | ||
| LWR (versus SWR) | 3.45 (2.99–3.98) | <0.001 |
| MWR (versus SWR) | 2.20 (1.91–2.55) | <0.001 |
| MELD exception listing year | ||
| 2010–2014 (versus 2005–2009) | 1.86 (1.69–2.04) | <0.001 |
| Age (per year) | 1.02 (1.01–1.02) | <0.001 |
| HBV (versus HCV) | 0.64 (0.51–0.81) | <0.001 |
| Laboratory MELD ≥15 (versus <15) | 2.06 (1.88–2.26) | <0.001 |
| AFP | ||
| 21–100 ng/mL (versus ≤20) | 1.25 (1.12–1.40) | <0.001 |
| 101–500 ng/mL (versus ≤20) | 1.55 (1.36–1.76) | <0.001 |
| 501–1000 ng/mL (versus ≤20) | 2.19 (1.74–2.77) | <0.001 |
| >1000 ng/mL (versus ≤20) | 3.01 (2.50–3.62) | <0.001 |
| Initial tumor burden | ||
| 1 lesion 3.1–5.0 cm (versus 1 lesion 2–3 cm) | 1.38 (1.24–1.53) | <0.001 |
| 2 lesions (versus 1 lesion 2–3 cm) | 1.23 (1.10–1.37) | <0.001 |
| 3 lesions (versus 1 lesion 2–3 cm) | 1.37 (1.17–1.61) | <0.001 |
| Received LRT Prior to LT | 0.70 (0.64–0.77) | <0.001 |
NOTE: LWR is regions 1, 5, and 9; MWR is regions 2, 4, 6, 7, and 8; and SWR is regions 3, 10, and 11.